Can Music Therapy Effectively Curb Diabetes? Recent Musings

Music therapy has gained increasing attention as a non-pharmacological intervention capable of influencing multiple physiological systems that are directly relevant to glucose regulation and metabolic health. Growing evidence from animal models and mechanistic cellular studies indicates that structured auditory stimulation and controlled musical exposure can modulate key neurobiological and endocrine pathways implicated in diabetes. Specifically, music-driven neuromodulation has been shown to alter hypothalamic–pituitary–adrenal (HPA) axis activity, rebalance autonomic nervous system tone, suppress stress-induced inflammatory signaling, and reduce oxidative stress. Emerging studies further suggest that music exposure can influence gut microbiota composition and metabolic signaling, thereby indirectly affecting insulin sensitivity and glucose homeostasis. In parallel, innovative synthetic-biology and engineered-cell approaches have demonstrated that sound-responsive systems may directly regulate insulin secretion, providing a novel proof-of-concept for music-linked metabolic control. This chapter synthesizes recent experimental and early translational literature supporting the proposition that music-based interventions can attenuate hyperglycaemia, enhance insulin responsiveness, and mitigate diabetes-associated pathophysiology. Mechanistic pathways are critically discussed, outcomes from rodent models are summarized, and methodological limitations and confounding variables are evaluated.